Litcius/Paper detail

Efficacy and safety of PARP inhibitors in the treatment of advanced ovarian cancer: An updated systematic review and meta-analysis of randomized controlled trials

Jiatao Hao, Ying Liu, Taohong Zhang, Jinmei He, Haoyi Zhao, Ruifang An, Yan Xue

2020Critical Reviews in Oncology/Hematology51 citationsDOI

Topics & Concepts

Internal medicineMedicineNauseaAdverse effectPARP inhibitorHazard ratioNeutropeniaVomitingOncologyMucositisRadiation therapyChemotherapyConfidence intervalPoly ADP ribose polymerasePolymeraseBiochemistryChemistryGenePARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentAdvanced Breast Cancer Therapies
Efficacy and safety of PARP inhibitors in the treatment of advanced ovarian cancer: An updated systematic review and meta-analysis of randomized controlled trials | Litcius